WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...

Proposed INN: List 91 WHO Drug Information, Vol. 18, No. 2, 2004
190
AMENDMENTS TO PREVIOUS LISTS
MODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURES
MODIFICACIONES A LAS LISTAS ANTERIORES
Proposed International Non Proprietary Names (Prop. INN): List 71
Dénominations communes internationales proposées (DCI Prop.): Liste 71
Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 71
(WHO Drug Information, Vol. 8, No. 2, 1994)
p. 22 verteporfinum
verteporfin replace the graphic formula by the following:
vertéporfine remplacer la formule développée par la suivante:
verteporfina sustitúyase la fórmula desarrollada por:
H3CO O
O
H
OCH3 CH3 CH3 O R = H, R' = CH3 +
OR R = CH3, R' = H
NH N
Proposed International Non Proprietary Names (Prop. INN): List 78
Dénominations communes internationales proposées (DCI Prop.): Liste 78
Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 78
(WHO Drug Information, Vol. 11, No. 4, 1997)
H 3C
H 2C
p. 292 delete / supprimer / suprimáse insert / insérer / insértese
targininum tilargininum
targinine tilarginine
targinine tilarginine
targinina tilarginina
Proposed International Non Proprietary Names (Prop. INN): List 90
Dénominations communes internationales proposées (DCI Prop.): Liste 90
Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 90
(WHO Drug Information, Vol. 18, No. 1, 2004)
p. 55 eslicarbazepinum
eslicarbazepine replace the molecular formula by the following:
eslicarbazépine remplacer la formule brute par:
eslicarbazepina sustitúyase la fórmula empírica por:
C15H14N2O2
N
HN
CH 3
O
OR'
and enantiomer
et énantiomère
y enantiómero
p. 64 razaxabanum
razaxaban replace the description by the following:
1-(3-amino-1,2-benzisoxazol-5-yl)-N-{4-[2-(dimethylaminomethyl)-1H-imidazol-
1-yl]-2-fluorophenyl}-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide